Need to know:
Moderna and Novavaxs Covid-19 and influenza combination vaccine draws expert enthusiasm for efficacy owing to the formers mRNA vaccine technology and the latters noninferior data for its standalone protein subunit flu vaccine. They were less enthusiastic about Moderna and Pfizer/BioNTechs investigation for variant-specific or multivariant Covid-19 vaccines, noting nebulous commercial or practical value despite the studies having scientific importance.
Regarding the Covid-19/flu vaccines, the assets featuring two antigens should not interfere with each others efficacy when combined, and their side-effect profiles should be similar to standalone versions. The one notable caveat with this approach is that while flu has a predictable annual seasonality, the same cannot be said so far with Covid-19, which can make it tricky to pinpoint ideal distribution timelines for the combo. Novavaxs Phase I/II combo vaccine study (NCT04961541) has data expected in April, while Moderna is still in preclinical stage.
As for variant-specific or multivariant Covid-19 mRNA vaccines, the lack of expert enthusiasm is due to data from the current crop of vaccines showing they are still efficacious against recent variants of concern. Also, by the time a vaccine is tweaked to feature the most recent variant, there is the risk that the variant would no longer be prevalent in the community. Nonetheless, there is scientific rationale to these studies to demonstrate existing vaccine technologies can be adapted for future variants.
Modernas variant-specific vaccines are targeting Beta, Delta, or Omicron and the multivariant shot zeroing in on both Beta and Delta in a Phase II/III trial (NCT04927065). Pfizer/BioNTech are targeting Alpha/Delta in Phase II (NCT05004181). The Pfizer/BioNTech trial is estimated to end in April, while Modernas trial conclusion is expected March 2023.
A Covid-19/flu vaccine is attractive as it combines two preventive approaches into one, says Dr William Schaffner, an infectious diseases professor at Vanderbilt University. The combo can reduce vaccine hesitancy and ease the publics fatigue towards vaccinations, explains Rodney Rhode, PhD, chair and professor, Clinical Laboratory Science Program at Texas State University.
Novavaxs protein subunit combo vaccine features its yet-to-be US-authorised Covid-19 vaccine Nuvaxovid and its Phase III seasonal flu vaccine NanoFlu. Meanwhile, Modernas combo vaccine features its FDA-approved Covid-19 vaccine Spikevax and its seasonal flu vaccine mRNA-1010, with the latter standalone vaccines furthest study being a Phase I/II trial (NCT04956575).
For these combo vaccines to solidify their real-world value, experts say their flu vaccine element should improve upon available standalone flu vaccines. Existing flu vaccines typically offer 4060% protection. The combo vaccine should have at least 60% of protection for better uptake, Rhode says.
In a Phase III trial (NCT04120194), Novavaxs NanoFlu had noninferior immunogenicity to the active comparator Sanofis Fluzone quadrivalent vaccine. Even though NanoFlu is only noninferior, the added Covid-19 element to its combo will give an additional selling point, Rhode explains. There are no concerns that the combo version will be less effective versus the standalone flu vaccine as Novavax is using the same technology in flu and its Covid-19 vaccines, he adds.
Its only recently that mRNA technology started being investigated for flu and the shift is due to the success of Covid-19 mRNA vaccines, says Dr Reynold Panettieri, Jr, Vice Chancellor, Rutgers Institute for Translational Medicine and Science. And the mRNA technology has potential in increasing the efficacy of existing influenza vaccines, explains Rhode.
Modernas standalone mRNA-1010 flu vaccine produced positive interim Phase I data showing boosted influenza antibody titres in the participants ages 18 and older. Novavax preclinical data shows its combo vaccine produced high titre influenza haemagglutination inhibiting (HAI) antibody response to a viral infection, neutralising antibodies against influenza A and B strains, and maintained protection against SARS-CoV-2.
Yet such positive preclinical data does not guarantee the same results in human trials, Rhode says. The human immune system responds differently to dosing, the tested drugs have different interference with human proteins and enzyme kinetics, as well as the effects of antibody response longevity when compared to laboratory animals, he explains.
The two combos should also demonstrate that the efficacy of its Covid-19 vaccine element should not be compromised by the added flu vaccine, Panettieri says. Reduced efficacy when combined is a valid concern that would affect its marketability, Rhode explains. Reassuringly, there are no examples of less-efficacious combo vaccines that are still distributed versus any standalone counterparts, he notes.
The combo vaccines are likely to have similar side effects to standalone versions, such as soreness, muscle fatigue, fever, and nausea, Rhode adds. So far, existing combo vaccines are as safe as standalone versions, Rhode and Panettieri note.
Nevertheless, if a combo vaccine is authorised, there are rollout issues that need to be addressed. There is an established seasonality to flu, which is why it is updated every year with a predictable schedule, adds John McCauley, director of the Worldwide Influenza Centre at the Francis Crick Institute.
Covid-19s seasonality, while there is a trend for winter peaks, is still nebulous and there are still questions if people should be given a Covid-19 vaccine annually to address waning efficacy, or only when there is an aggressive new variant that significantly impacts vaccine efficacy. You have to be really stringent and on top of your genomic surveillance. The world needs to continuously be looking at these strains and new variants, Rhode says.
Meanwhile, efforts for variant-specific or multivariant Covid-19 mRNA vaccines are also underway. While the first crop of Covid-19 mRNA vaccines demonstrated at least 90% efficacy against the original variant, approaching this high level of efficacy will be challenging at present due to vaccination rates in the community, immunity from prior infections, as well as more aggressive variants. Comparing previous and current immunogenicity data is like comparing apples to oranges, Panettieri says.
Nonetheless, there is nebulous practical and commercial value to these variant-specific or multivariant Covid-19 vaccines considering the original vaccines are still robust against all variants, Panettieri says. We have to be careful trying to perfect something that is not broken, he says. Boosters reduced the morbidity and hospitalization of infected patients, he added. Three doses of original Pfizer and Moderna vaccines had 90% protection against severe disease caused by the Omicron variant, according to the UKs Health Security Agency.
Further, by the time variant-specific or multivalent vaccines may be available in the market, the variants they are investigating against may no longer be circulating, a vaccine expert says. You will always be chasing your tail to a degree, he adds.
Instead, there should be more effort in improving vaccine distribution rather than improving upon a vaccine that is still efficacious, the vaccine expert says. Moderna has announced giving access to technology producing its Covid-19 vaccine to low- and mid-income countries, with BioNTech providing modular mRNA manufacturing facilities to improve vaccine supply in Africa.
Nonetheless, there is still scientific value in investigating these variant-specific or multivalent vaccines as they might be valuable if we do need them in the future, says the vaccine expert. A Pfizer spokesperson says staying vigilant against the virus requires identifying new ways to protect as SARS-CoV-2 naturally evolves. Developing and investigating different approaches, should they be needed, are essential towards their goal, she adds.
Moderna has said previous research on SARS-CoV-1 and MERS enabled the company to rapidly respond to the Covid-19 pandemic. Moderna and Novavax did not respond to the comment request.
Moderna is only investigating its vaccine as a booster, while Pfizer and BioNTech are also studying their vaccine in vaccine-nave people. While a significant number of people have received two doses, which argues for only investigating these as boosters, there are many people who are still vaccine-nave, particularly in places that are harder to reach, he added.
Reassuringly, variant-specific or multivariant vaccines are unlikely to pose a higher side-effect risk than the original version, Schaffner says. The side effects are attributed to the technology of the vaccine and not the antigen, he explains.
Clinical Data Management and Biostatistical Services
Here is the original post:
Covid-19, flu combo vaccines an advance but with distribution quandaries - Clinical Trials Arena
- How dogs are paving the way for human longevity drugs - Longevity.Technology - April 12th, 2024 [April 12th, 2024]
- Innovative Approaches to Improving Human Longevity - Securities.io - April 12th, 2024 [April 12th, 2024]
- Top 5 Companies Offering Solutions to Increased Human Longevity - Securities.io - April 12th, 2024 [April 12th, 2024]
- Morning Medical Update: Gut bacteria and longevity; People with ... - Medical Economics - June 12th, 2023 [June 12th, 2023]
- Artificial Intelligence and the Aging Process: A Match Made for ... - Down to Game - June 12th, 2023 [June 12th, 2023]
- Saint Bernard Lifespan: How Long Do Saint Bernards Live? - AZ Animals - June 12th, 2023 [June 12th, 2023]
- 'Human Resources' Was Poised to Be Netflix's Longest-Running ... - PRIMETIMER - June 12th, 2023 [June 12th, 2023]
- Early Life Adversity Doesn't Affect Gorillas Like Other Species - The Good Men Project - June 12th, 2023 [June 12th, 2023]
- Wellness luminaries, experts to meet in KK - The Borneo Post - June 12th, 2023 [June 12th, 2023]
- I grew up with hazardous smoke from forest fires in Asia. Here's what ... - Morningstar - June 12th, 2023 [June 12th, 2023]
- Workplace Networks Are More Important than Promotions to Engage ... - GlobeNewswire - June 12th, 2023 [June 12th, 2023]
- Accenture staff working at Google training AI move to unionise - The Australian Financial Review - June 12th, 2023 [June 12th, 2023]
- Hair Wigs and Extension Market Size to Grow by USD 5.26 billion from 2021 to 2026, Growth Driven by Technologi - Black Enterprise - April 10th, 2023 [April 10th, 2023]
- Want to age like a fine wine? Here are some tips for longevity and feeling younger - The Indian Express - February 18th, 2023 [February 18th, 2023]
- Human body | Organs, Systems, Structure, Diagram, & Facts - January 27th, 2023 [January 27th, 2023]
- Human | Avatar Wiki | Fandom - January 27th, 2023 [January 27th, 2023]
- Calorie Restriction and Fasting Diets: What Do We Know? - January 4th, 2023 [January 4th, 2023]
- Emma Thompson On Longevity Of Holiday Fave Love Actually But It Is SEX Actually That Is Earning Her Awards Buzz In Leo Grande - Deadline - December 26th, 2022 [December 26th, 2022]
- Heads or tails: What statistical models tell us about the probability of living beyond 110 - The Conversation - December 12th, 2022 [December 12th, 2022]
- LinkedIn founder and VC Reid Hoffman says human amplification via A.I. will revolutionize large enterprises in the next five years - Fortune - December 12th, 2022 [December 12th, 2022]
- Human hibernation is possible and could boost longevity | New Scientist - December 2nd, 2022 [December 2nd, 2022]
- Home - Human Longevity Institute - October 23rd, 2022 [October 23rd, 2022]
- Exercise: 7 benefits of regular physical activity - Mayo Clinic - October 23rd, 2022 [October 23rd, 2022]
- Life expectancy - Wikipedia - October 13th, 2022 [October 13th, 2022]
- Life Expectancy - Our World in Data - October 13th, 2022 [October 13th, 2022]
- The Longevity Investors Conference Gstaad brought together longevity experts and deep-pocketed investors - Cointelegraph - October 13th, 2022 [October 13th, 2022]
- The Search for a Pill That Can Help Dogsand HumansLive Longer - WIRED - October 13th, 2022 [October 13th, 2022]
- Aging of the Heart Correlates With a Poor Gut Microbiome - Lifespan.io News - October 13th, 2022 [October 13th, 2022]
- Aditxt, Inc. (Nasdaq: ADTX) Announces Development and Publication of a Mathematical Model for Predicting Longevity and Variations of Immune Response... - October 13th, 2022 [October 13th, 2022]
- FOXO Technologies Announces First Distribution Partner and Begins Product Rollout in California; Expands Executive Team With Insurance Industry Talent... - October 13th, 2022 [October 13th, 2022]
- A conversation with Holocaust scholar Dr. Irving Berkowitz - South Florida Sun Sentinel - October 13th, 2022 [October 13th, 2022]
- Nine postdoctoral fellowships in aging research awarded by the Glenn Foundation for Medical Research and AFAR - EurekAlert - October 13th, 2022 [October 13th, 2022]
- The 5 Wellness Habits That Slow Down Aging, Science Reveals Eat This Not That - Eat This, Not That - October 13th, 2022 [October 13th, 2022]
- Winning Federal Contracts on the Top 20 Contract Vehicles - Bloomberg Government - October 13th, 2022 [October 13th, 2022]
- Lawrence Austin promoted to rank of colonel - Winona Times - October 13th, 2022 [October 13th, 2022]
- The longevity dividend: Work in an era of 100-year lives - October 2nd, 2022 [October 2nd, 2022]
- Retirement Savings Calculator - Northwestern Mutual - October 2nd, 2022 [October 2nd, 2022]
- Clues to Human Longevity Unearthed in Largescale Mouse Genetic Study - Genetic Engineering & Biotechnology News - October 2nd, 2022 [October 2nd, 2022]
- Can we find ways to live beyond 100? Millionaires are betting on it. - MIT Technology Review - October 2nd, 2022 [October 2nd, 2022]
- Restrict Calories to Boost Immune Function - The Epoch Times - October 2nd, 2022 [October 2nd, 2022]
- The Black Progress Index: Examining the social factors that influence Black well-being - Brookings Institution - October 2nd, 2022 [October 2nd, 2022]
- Kevin Williamson on Scream 6 and Franchise Longevity - Bleeding Cool News - October 2nd, 2022 [October 2nd, 2022]
- 507-Year-Old Clam May Be the World's Oldest Living Being - History of Yesterday - October 2nd, 2022 [October 2nd, 2022]
- I should look forward to early retirement, but I think I'm dreading it - CBC.ca - October 2nd, 2022 [October 2nd, 2022]
- International Coffee Day 2022: How The Beloved Brew Helps Fight Cancer, Kidney Disease And Depression - ABP Live - October 2nd, 2022 [October 2nd, 2022]
- Corey Feldman And Jamison Newlander Talk The Lost Boys And The Birth Of The Two Coreys - Forbes - October 2nd, 2022 [October 2nd, 2022]
- Proven Levels of Human Longevity | NextBigFuture.com - September 11th, 2022 [September 11th, 2022]
- Prolonging healthspan by delaying ageing -- NUHS opens Singapore's first Centre for Healthy Longevity to increase healthy lifespan of Singapore... - September 11th, 2022 [September 11th, 2022]
- What is the Secret to Longevity in Real Estate? - CandysDirt.com - Candy's Dirt - September 11th, 2022 [September 11th, 2022]
- Jeff Stukey & Jay Olshansky, Ph.D with Wealthspan Advisors, Interviewed on the Influential Entrepreneurs Podcast Discussing How Aging Science... - September 11th, 2022 [September 11th, 2022]
- The Queen of the World - The Atlantic - September 11th, 2022 [September 11th, 2022]
- THR Icon: At 100, Norman Lear Looks Back (And Ahead) at Whats Changed Since the Maude Abortion Episode - Hollywood Reporter - September 11th, 2022 [September 11th, 2022]
- TIFF 2022: The Colour of Ink Review - ThatShelf.com - September 11th, 2022 [September 11th, 2022]
- Should Age Be on the Ballot? - Next Avenue - September 11th, 2022 [September 11th, 2022]
- Was The Spring Water At Balmoral Castle The Secret To Elizabeth II's Longevity? - Nation World News - September 11th, 2022 [September 11th, 2022]
- A complete guide to the health benefits of nuts europeantimes.news - The European Times - September 11th, 2022 [September 11th, 2022]
- Debut Launches its Bio2Consumer Platform to Become the Leader in Vertically Integrated Synthetic Biology - PR Web - September 11th, 2022 [September 11th, 2022]
- Rapamycin Drug Used in Cancer Therapy Found to Increase Human Lifespan [Study] - Nature World News - August 30th, 2022 [August 30th, 2022]
- Eating Healthy: Why Eating Grapes Would Increase Lifespan | The Guardian Nigeria News - Nigeria and World News Guardian Life The Guardian Nigeria... - August 30th, 2022 [August 30th, 2022]
- Beauty Bets on Longevity WWD - WWD - August 30th, 2022 [August 30th, 2022]
- Analysis of the impact of success on three dimensions of sustainability in 173 countries | Scientific Reports - Nature.com - August 30th, 2022 [August 30th, 2022]
- You might have glowing skin in no time by making few easy changes to your skincare routine - TDPel Media - August 30th, 2022 [August 30th, 2022]
- Nucleai Appoints New Head of Pathology to Support Expansion in Biopharmaceutical and Clinical Markets - Business Wire - August 8th, 2022 [August 8th, 2022]
- Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates - AiThority - August 8th, 2022 [August 8th, 2022]
- Prolonged and intense heatwave affecting parts of western and northern Europe breaks temperature records; globally, July 2022 was one of three warmest... - August 8th, 2022 [August 8th, 2022]
- YLEM: Augmenting sustainable futures through material exploration and testing - STIRworld - August 8th, 2022 [August 8th, 2022]
- Do you want to live forever? Big Tech and the quest for eternal youth - The New Statesman - August 6th, 2022 [August 6th, 2022]
- This startup wants to copy you into an embryo for organ harvesting - MIT Technology Review - August 6th, 2022 [August 6th, 2022]
- Renewal Bio Acquires Breakthrough Stem Cell Technology With Applications in Infertility and Longevity - Benzinga - August 6th, 2022 [August 6th, 2022]
- Get married or get a degree to live longer says study, debunking theories of womens longevity over men - Times Now - August 6th, 2022 [August 6th, 2022]
- Nucleai Appoints New Head of Pathology to Support Expansion in Biopharmaceutical and Clinical Markets - StreetInsider.com - August 6th, 2022 [August 6th, 2022]
- Some species are immortal but dying of old age is humanity's secret weapon - The Telegraph - August 6th, 2022 [August 6th, 2022]
- Opinion: Changing When and How Much We Eat May Extend Health Span - The Scientist - August 6th, 2022 [August 6th, 2022]
- Vieroots uses genome testing to win over a growing tribe of wellness enthusiasts - YourStory - August 6th, 2022 [August 6th, 2022]
- Herbs radiate and give you youthful skin - The Hans India - August 6th, 2022 [August 6th, 2022]
- How Pop Culture, Politics, Science, and Business Got So Old - The Atlantic - August 6th, 2022 [August 6th, 2022]
- John Hood: How to read this column | Columnists | journalnow.com - Winston-Salem Journal - August 6th, 2022 [August 6th, 2022]
- How Long Is The Human Lifespan? Here's What Studies Have Found | mindbodygreen - mindbodygreen - July 31st, 2022 [July 31st, 2022]
- Employees are livingand workinglonger. CEOs are introducing initiatives like phased retirements to harness the longevity economy - Fortune - July 31st, 2022 [July 31st, 2022]
- Why Do We Get Old, and Can Aging Be Reversed? - Quanta Magazine - July 31st, 2022 [July 31st, 2022]